Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCentrica Regulatory News (CNA)

Share Price Information for Centrica (CNA)

Share Price is delayed by 15 minutes
Get Live Data
186.10    1.00 (0.54%)
Bid:
186.05
Ask:
186.15
Spread: 0.10 (0.054%)
Market Cap: £8.43b
CNA Live PriceLast checked at - London Stock Exchange

Intraday Centrica Share Chart

Stabilisation Notice

14 May 2024 08:59

RNS Number : 3409O
J.P. Morgan Securities PLC.
14 May 2024
 

14th May 2024

Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful.

Centrica plc Pre-stabilisation Period Announcement

J.P. Morgan Securities plc, (contact: Marc Lewell +442071342468) hereby gives notice, as Stabilisation Coordinator, that the Stabilising Manager(s) named below may stabilise the offer of the following securities in accordance with Commission Delegated Regulation EU/xxx/2016 under the Market Abuse Regulation (EU/596/2016).

The securities:

Issuer:

Centrica plc

Guarantor (if any):

N/A

Aggregate nominal amount:

GBP bmk

Description:

GBP 12-yr-Non-Call-6-year FXD Subordinated Notes

Listing: London Stock Exchange

Offer price:

TBC

Other offer terms:

GBP 100k x 1k

Stabilisation: Relevant Stabilisation regulation applies 

Stabilisation Manager(s):

J.P. Morgan Securities plc (Stabilisation coordinator)

Barclays (Stabilisation manager)

NatWest Markets (Stabilisation manager)

Societe Generale (Stabilisation manager)

Stabilisation period expected to start on:

14th May 2024

Stabilisation period expected to end no later than:

14th June 2024

 

Existence, maximum size and conditions of use of overallotment facility:

The Stabilisation Manager(s) may over-allot the securities in an amount not exceeding 5% of the aggregate nominal amount stated above.

Stabilisation trading venue:

Over the counter, TBC

 

In connection with the offer of the above securities, the Stabilising Manager(s), or persons acting on behalf of the Stabilising Manager(s) may over-allot the securities, provided that the aggregate principal amount of the securities allotted does not exceed 105 percent of the aggregate principal amount of the securities, or effect transactions with a view to supporting the market price of the securities at a level higher than that which might otherwise prevail. However, stabilisation may not necessarily occur and any stabilisation action, if begun, may cease at any time, but it must end no later than the earlier of 30 days after the issue date of the securities and 60 days after the date of allotment of the securities.

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

This announcement and the offer of the securities to which it relates are only addressed to and directed at persons outside the United Kingdom and persons in the United Kingdom who have professional experience in matters related to investments or who are high net worth persons within Article 12(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 and must not be acted on or relied on by other persons in the United Kingdom.

In addition, if and to the extent that this announcement is communicated in, or the offer of the securities to which it relates is made in, any EEA Member State that has implemented Directive 2003/71/EC (together with any applicable implementing measures in any Member State, the "Prospectus Directive") before the publication of a prospectus in relation to the securities which has been approved by the competent authority in that Member State in accordance with the Prospectus Directive (or which has been approved by a competent authority in another Member State and notified to the competent authority in that Member State in accordance with the Prospectus Directive), this announcement and the offer are only addressed to and directed at persons in that Member State who are qualified investors within the meaning of the Prospectus Directive (or who are other persons to whom the offer may lawfully be addressed) and must not be acted on or relied on by other persons in that in that Member State

This announcement is not an offer of securities for sale into the United States. The securities have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There will be no public offer of securities in the United States.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STAEAXSLFSXLEEA
Date   Source Headline
1st Jun 20263:45 pmRNSTotal Voting Rights
26th May 202612:30 pmRNSDirector/PDMR Shareholding
22nd May 20262:00 pmRNSDirector/PDMR Shareholding
18th May 20264:00 pmRNSDirector/PDMR Shareholding
15th May 20267:00 amRNSBritish Gas agrees PPM settlement
14th May 20264:42 pmRNSPublication of a Prospectus
12th May 20263:15 pmRNSDirector/PDMR Shareholding
12th May 202612:15 pmRNSDirector/PDMR Shareholding
12th May 20267:10 amRNSDirectorate change
7th May 202612:15 pmRNSResult of AGM
7th May 20267:00 amRNSAcquisition of the Severn CCGT for c.£370 million
7th May 20267:00 amRNSAGM Statement
1st May 20262:30 pmRNSTotal Voting Rights
27th Apr 20262:30 pmRNSDirector/PDMR Shareholding
13th Apr 20263:30 pmRNSDirector/PDMR Shareholding
1st Apr 202612:00 pmRNSTotal Voting Rights
31st Mar 202610:33 amRNSNotice of AGM
25th Mar 20262:00 pmRNSDirector/PDMR Shareholding
11th Mar 20266:15 pmRNSDirector/PDMR Shareholding
2nd Mar 202612:15 pmRNSTotal Voting Rights
25th Feb 20265:15 pmRNSDirector/PDMR Shareholding
19th Feb 20262:39 pmRNSAnnual Financial Report 2025
19th Feb 20267:10 amRNSDirectorate change
19th Feb 20267:00 amRNSPreliminary Results
11th Feb 20265:30 pmRNSDirector/PDMR Shareholding
9th Feb 20267:00 amRNSCentrica announces divestments
2nd Feb 20263:00 pmRNSTotal Voting Rights
26th Jan 20264:15 pmRNSDirector/PDMR Shareholding
13th Jan 20263:00 pmRNSDirector/PDMR Shareholding
13th Jan 20267:00 amRNSTransaction in Own Shares
12th Jan 20263:09 pmRNSTransaction in Own Shares - Replacement
12th Jan 20267:00 amRNSTransaction in Own Shares
9th Jan 20267:00 amRNSTransaction in Own Shares
8th Jan 20267:00 amRNSTransaction in Own Shares
7th Jan 20267:00 amRNSTransaction in Own Shares
6th Jan 20267:00 amRNSTransaction in Own Shares
5th Jan 20267:00 amRNSTransaction in Own Shares
2nd Jan 202612:30 pmRNSTotal Voting Rights
2nd Jan 20267:00 amRNSTransaction in Own Shares
2nd Jan 20267:00 amRNSTransaction in Own Shares
31st Dec 20257:00 amRNSTransaction in Own Shares
31st Dec 20257:00 amRNSTransaction in Own Shares
30th Dec 20257:00 amRNSTransaction in Own Shares
30th Dec 20257:00 amRNSTransaction in Own Shares
29th Dec 20254:30 pmRNSCancellation of treasury shares
29th Dec 20254:30 pmRNSCancellation of treasury shares
29th Dec 20251:15 pmRNSDirector/PDMR Shareholding
29th Dec 20251:15 pmRNSDirector/PDMR Shareholding
29th Dec 20257:00 amRNSTransaction in Own Shares
29th Dec 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.